KOREA PHARMA Co., Ltd.

Research KOREA PHARMA Co., Ltd. (032300.KQ) on Bullrun: market cap KRW 90.20B, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 90.20B; dividend yield is 0.6%.

Peer valuation comparison

Latest dividend yield is 0.6% versus a Healthcare sector median of 2.4% (75.0% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 90.20Bn/a0.6%50

Dividend history

Latest trailing dividend snapshot: annual dividend/share 50 KRW, yield 0.6%.

About KOREA PHARMA Co., Ltd.

KOREA PHARMA Co., Ltd. produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is KOREA PHARMA Co., Ltd.'s market cap?

KOREA PHARMA Co., Ltd.'s market capitalization is KRW 90.20B.

Does KOREA PHARMA Co., Ltd. pay a dividend?

KOREA PHARMA Co., Ltd. has a dividend yield of 0.6%.

What does KOREA PHARMA Co., Ltd. do?

KOREA PHARMA Co., Ltd. produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.